Regeneron CEO: Trump 'is a case of one' and 'weakest evidence' for Covid-19 treatment
Regeneron chief executive Leonard Schleifer on Sunday said President Donald Trump's treatment with the company's experimental antibody cocktail is "a case of one," but stressed ongoing clinical trials still need to show its efficacy.
"The president's case is a case of one, and that's what we call a case report, and it is evidence of what's happening, but it's kind of the weakest evidence that you can get," Schleifer said in an interview on CBS' "Face the Nation."
Schleifer added that there were "some very interesting aspects" in Trump's case, such as his age. He also noted that the president "had some risk factors," and that Trump "did not have his own immune system in gear when he was sick and he got treated" with Regeneron's treatment.
https://www.politico.com/news/2020/10/11/regeneron-trump-covid-coronavirus-428691